Selected research
Industry Research
Nifedipine Industry Research Report 2026
Market perspective
The global Nifedipine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Nifedipine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Nifedipine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Nifedipine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Nifedipine include Actavis, Bayer, Honglin Pharmaceutical, Huanghai, Pfizer, Lifeon Pharmaceutical, Teva, Simcere and Shyndec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Nifedipine market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nifedipine Market by Company
Actavis
Bayer
Honglin Pharmaceutical
Huanghai
Pfizer
Lifeon Pharmaceutical
Teva
Simcere
Shyndec
Yabao
ApicHope
EASEHEAL Pharmaceutical
Nifedipine Segment by Type
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
Nifedipine Segment by Application
Hypertension
Heart Disease
Other
Nifedipine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nifedipine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nifedipine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nifedipine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nifedipine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nifedipine Controlled Release Tablets
- Nifedipine Extended Action Tablets
Applications
- Hypertension
- Heart Disease
- Other
Companies covered
- Actavis
- Bayer
- Honglin Pharmaceutical
- Huanghai
- Pfizer
- Lifeon Pharmaceutical
- Teva
- Simcere
- Shyndec
- Yabao
- ApicHope
- EASEHEAL Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nifedipine Market Size (2021-2032)
- 2.2.2 Global Nifedipine Sales (2021-2032)
- 2.2.3 Global Nifedipine Market Average Price (2021-2032)
- 2.3 Nifedipine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Nifedipine Controlled Release Tablets
- 2.3.3 Nifedipine Extended Action Tablets
- 2.4 Nifedipine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hypertension
- 2.4.3 Heart Disease
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nifedipine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Nifedipine Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Nifedipine Revenue of Manufacturers (2021-2026)
- 3.4 Global Nifedipine Average Price by Manufacturers (2021-2026)
- 3.5 Global Nifedipine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Nifedipine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nifedipine, Product Type & Application
- 3.8 Global Manufacturers of Nifedipine, Established Date
- 3.9 Global Nifedipine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Actavis
- 4.1.1 Actavis Company Information
- 4.1.2 Actavis Business Overview
- 4.1.3 Actavis Nifedipine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Actavis Nifedipine Product Portfolio
- 4.1.5 Actavis Recent Developments
- 4.2 Bayer
- 4.2.1 Bayer Company Information
- 4.2.2 Bayer Business Overview
- 4.2.3 Bayer Nifedipine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bayer Nifedipine Product Portfolio
- 4.2.5 Bayer Recent Developments
- 4.3 Honglin Pharmaceutical
- 4.3.1 Honglin Pharmaceutical Company Information
- 4.3.2 Honglin Pharmaceutical Business Overview
- 4.3.3 Honglin Pharmaceutical Nifedipine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Honglin Pharmaceutical Nifedipine Product Portfolio
- 4.3.5 Honglin Pharmaceutical Recent Developments
- 4.4 Huanghai
- 4.4.1 Huanghai Company Information
- 4.4.2 Huanghai Business Overview
- 4.4.3 Huanghai Nifedipine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Huanghai Nifedipine Product Portfolio
- 4.4.5 Huanghai Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Nifedipine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Nifedipine Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Lifeon Pharmaceutical
- 4.6.1 Lifeon Pharmaceutical Company Information
- 4.6.2 Lifeon Pharmaceutical Business Overview
- 4.6.3 Lifeon Pharmaceutical Nifedipine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Lifeon Pharmaceutical Nifedipine Product Portfolio
- 4.6.5 Lifeon Pharmaceutical Recent Developments
- 4.7 Teva
- 4.7.1 Teva Company Information
- 4.7.2 Teva Business Overview
- 4.7.3 Teva Nifedipine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Teva Nifedipine Product Portfolio
- 4.7.5 Teva Recent Developments
- 4.8 Simcere
- 4.8.1 Simcere Company Information
- 4.8.2 Simcere Business Overview
- 4.8.3 Simcere Nifedipine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Simcere Nifedipine Product Portfolio
- 4.8.5 Simcere Recent Developments
- 4.9 Shyndec
- 4.9.1 Shyndec Company Information
- 4.9.2 Shyndec Business Overview
- 4.9.3 Shyndec Nifedipine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shyndec Nifedipine Product Portfolio
- 4.9.5 Shyndec Recent Developments
- 4.10 Yabao
- 4.10.1 Yabao Company Information
- 4.10.2 Yabao Business Overview
- 4.10.3 Yabao Nifedipine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Yabao Nifedipine Product Portfolio
- 4.10.5 Yabao Recent Developments
- 4.11 ApicHope
- 4.11.1 ApicHope Company Information
- 4.11.2 ApicHope Business Overview
- 4.11.3 ApicHope Nifedipine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 ApicHope Nifedipine Product Portfolio
- 4.11.5 ApicHope Recent Developments
- 4.12 EASEHEAL Pharmaceutical
- 4.12.1 EASEHEAL Pharmaceutical Company Information
- 4.12.2 EASEHEAL Pharmaceutical Business Overview
- 4.12.3 EASEHEAL Pharmaceutical Nifedipine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 EASEHEAL Pharmaceutical Nifedipine Product Portfolio
- 4.12.5 EASEHEAL Pharmaceutical Recent Developments
5 Global Nifedipine Market Scenario by Region
- 5.1 Global Nifedipine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nifedipine Sales by Region: 2021-2032
- 5.2.1 Global Nifedipine Sales by Region: 2021-2026
- 5.2.2 Global Nifedipine Sales by Region: 2027-2032
- 5.3 Global Nifedipine Revenue by Region: 2021-2032
- 5.3.1 Global Nifedipine Revenue by Region: 2021-2026
- 5.3.2 Global Nifedipine Revenue by Region: 2027-2032
- 5.4 North America Nifedipine Market Facts & Figures by Country
- 5.4.1 North America Nifedipine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Nifedipine Sales by Country (2021-2032)
- 5.4.3 North America Nifedipine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Nifedipine Market Facts & Figures by Country
- 5.5.1 Europe Nifedipine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Nifedipine Sales by Country (2021-2032)
- 5.5.3 Europe Nifedipine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Nifedipine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nifedipine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Nifedipine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Nifedipine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nifedipine Market Facts & Figures by Country
- 5.7.1 South America Nifedipine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Nifedipine Sales by Country (2021-2032)
- 5.7.3 South America Nifedipine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Nifedipine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nifedipine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Nifedipine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Nifedipine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Nifedipine Sales by Type (2021-2032)
- 6.1.1 Global Nifedipine Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Nifedipine Sales Market Share by Type (2021-2032)
- 6.2 Global Nifedipine Revenue by Type (2021-2032)
- 6.2.1 Global Nifedipine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Nifedipine Revenue Market Share by Type (2021-2032)
- 6.3 Global Nifedipine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Nifedipine Sales by Application (2021-2032)
- 7.1.1 Global Nifedipine Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Nifedipine Sales Market Share by Application (2021-2032)
- 7.2 Global Nifedipine Revenue by Application (2021-2032)
- 7.2.1 Global Nifedipine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Nifedipine Revenue Market Share by Application (2021-2032)
- 7.3 Global Nifedipine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nifedipine Value Chain Analysis
- 8.1.1 Nifedipine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nifedipine Production Mode & Process
- 8.2 Nifedipine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nifedipine Distributors
- 8.2.3 Nifedipine Customers
9 Global Nifedipine Analyzing Market Dynamics
- 9.1 Nifedipine Industry Trends
- 9.2 Nifedipine Industry Drivers
- 9.3 Nifedipine Industry Opportunities and Challenges
- 9.4 Nifedipine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst